A Prospective Randomized, single centre, two arm open label trial to evaluate the efficacy of daily and weekly high dose vitamin D (Cholecalciferol) in Rheumatoid Arthritis patients â?? A Pilot Study.

Dr Arindam Nandy Roy0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Are between the age of 18 to 60.
•2. Subjects of either gender with documented Vitamin D deficiency (Serum 25(OH) D level of <20 ng/ml ( <50 nmol/L).
•3. Are clinically diagnosed with RA (according to ACR 2010 criteria) (7).
•4. Have active disease defined by Simplified Disease Activity Index (SDAI) >3.3(8).

•1. Hypersensitivity to cholecalciferol (Vitamin D).
•2. Pregnant and lactating women.
•3. History of renal or any metabolic disease.
•4. Subjects having arthritis other than Rheumatoid.
•5. Any illness that could impair their ability to comply with the study, or are enrolled in another study.
•6. Subjects willing to stop calcium/Multivitamin supplements at the time of consent.
•7. Plan to start with biological agents.
•8. Mental illness impairing ability to comply with study.

发起方

Dr Arindam Nandy Roy